The emergence of nitazenes: a new chapter in the synthetic opioid crisis
The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Abstract
As reported by United Nation Office on Drugs and Crime (UNODC), opioids are the first class of psychotropic substances worldwide in terms of overdose deaths and the second most widely used. In North America, particularly the United States, what was a dramatic decade-long opioid dependence has now escalated to persistent health emergency. Here, the number of overdose deaths has risen markedly since the appearance of several more and more potent synthetic opioids, in particular fentanyl and its structural analogs. The restrictions applied to the fentanyl class have effectively produced a progressive decrease in UNODC reports of new derivatives, but illegal markets have been able to adapt quickly by turning to a new class of synthetic opioid receptor agonists, the nitazenes, characterized by potent side effects that prevented any safe use as sedative and analgesic drugs. Since the appearance of isotonitazene in 2019, the scientific community has been challenged in the identification and characterization of new structural analogs, the study of their pharmacodynamics and pharmacokinetics, the identification of corresponding metabolites, and the development of analytical methods able to identify and quantify these compounds even at the near or sub ng/mL concentrations at which they are present in biological samples. The purpose of this review, 6 years after the emergence of the phenomenon, is therefore to present an updated overview of the knowledge gained and the progress made in enhancing the tools available to forensic toxicologists, ultimately supporting efforts to fight the spread of this dangerous class of abused substances.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although this action aimed to reduce IMF availability, it may have inadvertently created an opening for the introduction of a new subclass of synthetic opioids: nitazene analogs [3, 5, 6].”
From Temporal and geographical patterns of nitazene detections in drug samples and biospecimens in the United States, 2019–2024 (2026) · cites this paper as [6]
In the citing paper
“Although studies from the US, Australia and Europe (including the United Kingdom, Norway and Estonia) have documented a high prevalence of polysubstance involvement with nitazenes [6, 32, 45, 46, 47], there remains a very limited understanding of where along the drug supply chain nitazenes are introduced.”
From Temporal and geographical patterns of nitazene detections in drug samples and biospecimens in the United States, 2019–2024 (2026) · cites this paper as [6]
Citations
Cites
Harper, L., Powell, J., & Pijl, E. M. (2017) · Harm Reduction Journal · doi:10.1186/s12954-017-0179-5 · Cited by 337 · cited 1×
“…to quickly identify NPS on site at low operating costs, minimal technical training of personnel but with competitive analytical performance in terms of limit of detection, specificity, and selectivity (Gozdzialski et al. 2023; Harper et al. 2017; Mullin et al. 2023; Williams et al. 2023).”
Hair Analysis for Drug Detection
Kintz, P., Villain, M., & Cirimele, V. (2006) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000211811.27558.b5 · Cited by 220 · cited 1×
“This results in an extended detection window with respect to other biological samples, such as blood and urine (Kintz et al. 2006).”
Dried blood spots in toxicology: from the cradle to the grave?
Stove, C. P., Ingels, A.-S. M. E., De Kesel, P. M. M., & Lambert, W. E. (2012) · Critical Reviews in Toxicology · doi:10.3109/10408444.2011.650790 · Cited by 186 · cited 1×
“Recent advancements have focused on automating sample preparation and analysis to further enhance its applicability (Stove et al. 2012; Ververi et al. 2023).”
Kim, Y., Kumar, M. R., Park, N., Heo, Y., & Lee, S. (2011) · The Journal of Organic Chemistry · doi:10.1021/jo2019416 · Cited by 182 · cited 1×
“In 2011, Kim et al. (2011) published a copper (CuCl)-cat- alyzed, one-pot, three-component reaction to synthesize ben-zimidazole compounds in moderate to high yields (40–98%).”
Yang, D., Fokas, D., Li, J., Yu, L., & Baldino, C. (2004) · Synthesis · doi:10.1055/s-2004-834926 · Cited by 164 · cited 1×
“Another method published by Yang et al. (2005) involves a one-pot reductive cyclization of substituted 2-nitroanilines with various (hetero)aryl or alkyl aldehydes in the presence of sodium dithionite (Na 2 S 2 O 4 ).”
Vandeputte, M. M., Van Uytfanghe, K., Layle, N. K., St. Germaine, D. M., Iula, D. M., & Stove, C. P. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00064 · Cited by 161
Higher doses of naloxone are needed in the synthetic opioid era
Moss, R. B., & Carlo, D. J. (2019) · Substance Abuse Treatment, Prevention, and Policy · doi:10.1186/s13011-019-0195-4 · Cited by 155 · cited 1×
“However, with the advent first of fentanyls (Moss and Carlo 2019) and now of nitazenes (Berger et al. 2025), the overdose reversal through naloxone seems to require higher or repeated doses.”
Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework
Krotulski, A. J., Papsun, D. M., Kacinko, S. L., & Logan, B. K. (2020) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaa016 · Cited by 146 · cited 3×
“Several authors (Parks et al. 2024; Walton et al. 2022; Krotulski et al. 2020, 2021; Pucci et al. 2024; Schüller et al. 2023; Diekhans et al. 2024; Pardi et al. 2023) have developed and validated quantitative methods to detect nitazene analogs with LODs and LOQs at a near or sub ng/mL.”
DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles
Ujváry, I., Christie, R., Evans-Brown, M., Gallegos, A., Jorge, R., de Morais, J., & Sedefov, R. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00037 · Cited by 141 · cited 4×
“Additional rodent studies estimated metonitazene’s analgesic potency to be 30–100 times that of morphine, depending on the route of administration and the animal model employed (Ujváry et al. 2021).”
InfluentialPostmortem Drug Metabolism by Bacteria
Robertson, M., & Drummer, O. H. (1995) · Journal of Forensic Sciences · doi:10.1520/jfs13791j · Cited by 137 · cited 1×
“The rate of conversion depends on many factors, including the species of bacteria, the storage temperature, the presence of preservatives, and the pH (Robertson and Drummer 1995, 1998).”
Stability of Nitrobenzodiazepines in Postmortem Blood
Robertson, M., & Drummer, O. (1998) · Journal of Forensic Sciences · doi:10.1520/jfs16081j · Cited by 108 · cited 1×
“The rate of conversion depends on many factors, including the species of bacteria, the storage temperature, the presence of preservatives, and the pH (Robertson and Drummer 1995, 1998).”
Synthese basisch substituierter, analgetisch wirksamer Benzimidazol-Derivate
Hunger, A., Kebrle, J., Rossi, A., & Hoffmann, K. J. (1957) · Cellular and Molecular Life Sciences · doi:10.1007/bf02161116 · Cited by 103 · cited 2×
“Early preclinical studies indicated that the antinociceptive potency of metonitazene in mice is approximately 100 times greater than that of morphine at 5 mg/kg (Hunger et al. 1957, 1960a, b).”
Walton, S. E., Krotulski, A. J., & Logan, B. K. (2022) · Journal of Analytical Toxicology · doi:10.1093/jat/bkab117 · Cited by 92
Krotulski, A. J., Papsun, D. M., Walton, S. E., & Logan, B. K. (2021) · Drug Testing and Analysis · doi:10.1002/dta.3115 · Cited by 91 · cited 3×
“Several authors (Parks et al. 2024; Walton et al. 2022; Krotulski et al. 2020, 2021; Pucci et al. 2024; Schüller et al. 2023; Diekhans et al. 2024; Pardi et al. 2023) have developed and validated quantitative methods to detect nitazene analogs with LODs and LOQs at a near or sub ng/mL.”
Mueller, F., Bogdal, C., Pfeiffer, B., Andrello, L., Ceschi, A., Thomas, A., & Grata, E. (2021) · Forensic Science International · doi:10.1016/j.forsciint.2021.110686 · Cited by 82 · cited 2×
“…(such as qToF and Orbitrap), capillary electrophoresis (CE), X-ray crystallography, X-ray diffractometry, and UV–Vis spectrophotometry (Blanck-aert et al. 2021; Kanamori et al. 2023; Killoran et al. 2024; Monti et al. 2024; Mueller et al. 2021; Siczek et al. 2021; Vandeputte et al. 2022b).”
Vandeputte, M. M., Krotulski, A. J., Walther, D., Glatfelter, G. C., Papsun, D., Walton, S. E., Logan, B. K., Baumann, M. H., & Stove, C. P. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03276-4 · Cited by 80 · cited 1×
“In at least two cases, N -pyrro- lidino etonitazene was identified as the primary factor contributing to death, highlighting its toxic effects in humans (Vandeputte et al. 2022a).”
Gozdzialski, L., Wallace, B., & Hore, D. (2023) · Harm Reduction Journal · doi:10.1186/s12954-023-00764-3 · Cited by 76 · cited 1×
“…to quickly identify NPS on site at low operating costs, minimal technical training of personnel but with competitive analytical performance in terms of limit of detection, specificity, and selectivity (Gozdzialski et al. 2023; Harper et al. 2017; Mullin et al. 2023; Williams et al. 2023).”
Hunger, A., Kebrle, J., Rossi, A., & Hoffmann, K. (1960) · Helvetica Chimica Acta · doi:10.1002/hlca.19600430412 · Cited by 70 · cited 4×
“Early preclinical studies indicated that the antinociceptive potency of metonitazene in mice is approximately 100 times greater than that of morphine at 5 mg/kg (Hunger et al. 1957, 1960a, b).”
InfluentialÜber Benzimidazolderivate mit starker analgetischer Wirkung
Gross, F., & Turrian, H. (1957) · Cellular and Molecular Life Sciences · doi:10.1007/bf02161117 · Cited by 62 · cited 2×
“Calculations of the mouse iv LD 50 values suggested that etonitazene has a several-fold wider therapeutic window than morphine in the mouse (Gross and Turrian 1957).”
Bade, R., Eaglesham, G., Shimko, K. M., & Mueller, J. (2023) · Talanta · doi:10.1016/j.talanta.2022.123767 · Cited by 62 · cited 1×
“The order of magnitude of the water flow during the sampling period (megaliters) makes the analyte concentration as low as 0.01 ng/L. Bade et al. (2023, 2024) coped this issue mainly by solid-phase extraction (SPE) and concentration followed by LC–MS/MS. Chromatography separation was obtained on a…”
InfluentialDe Vrieze, L. M., Walton, S. E., Pottie, E., Papsun, D., Logan, B. K., Krotulski, A. J., Stove, C. P., & Vandeputte, M. M. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03774-7 · Cited by 58 · cited 1×
“One of the most extensive investigations into the in vitro functional activity of this opioid class at the MOR, based on the number of compounds analyzed, was performed by De Vrieze et al. (2024b).”
Non-Fentanyl New Synthetic Opioids—An Update
Zawilska, J. B., Adamowicz, P., Kurpeta, M., & Wojcieszak, J. (2023) · Forensic Science International · doi:10.1016/j.forsciint.2023.111775 · Cited by 55 · cited 1×
“Hence, as highlighted by the UNODC trend analyses, the growing prevalence of nitazenes among all synthetic opioids (Zawilska et al. 2023) suggests that given their potent opioid receptor activity, this class of compounds can replace natural opioids and possibly even fentanyl and its analogs.”
Mu-Opioid Receptor Selective Superagonists Produce Prolonged Respiratory Depression
Malcolm, N. J., Palkovic, B., Sprague, D. J., Calkins, M. M., Lanham, J. K., Halberstadt, A. L., Stucke, A. G., & McCorvy, J. D. (2023) · iScience · doi:10.1016/j.isci.2023.107121 · Cited by 53 · cited 1×
“Indeed, Malcolm et al. (2023) had demonstrated that isotonitazene and N -desethyl isotonitazene, when compared to conventional opioids such as fentanyl and morphine, exhibit markedly greater potency at the MOR relative to the KOR and DOR, with selectivity ratios of approximately 15,000-fold and…”
Glatfelter, G. C., Vandeputte, M. M., Chen, L., Walther, D., Tsai, M.-H. M., Shi, L., Stove, C. P., & Baumann, M. H. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06451-2 · Cited by 52 · cited 1×
“A comprehensive investigation into the pharmacology of this synthetic opioid subclass, with an emphasis on SAR, was conducted by Glatfelter et al. (2023).”
Trana, A. D., Mannocchi, G., Pirani, F., Maida, N. L., Gottardi, M., Pichini, S., & Busardò, F. P. (2020) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaa103 · Cited by 51 · cited 1×
“…with different resolution make it a successful choice for the targeted screening and quantitation of pharmacologically active compounds and their metabolites in biological specimens in routine applications (Ahmed et al. 2022; Di Trana et al. 2020; D’Ovidio et al. 2023; Vaiano et al. 2021).”
Papsun, D. M., Krotulski, A. J., & Logan, B. K. (2022) · American Journal of Forensic Medicine & Pathology · doi:10.1097/paf.0000000000000787 · Cited by 51 · cited 1×
“This is probably as a consequence of legal restriction in USA and China (Bao et al. 2019; Papsun et al. 2022).”
Hunger, A., Kebrle, J., Rossi, A., & Hoffmann, K. (1960) · Helvetica Chimica Acta · doi:10.1002/hlca.19600430323 · Cited by 49
State-of-the-Art Analytical Approaches for Illicit Drug Profiling in Forensic Investigations
Ahmed, R., Altamimi, M. J., & Hachem, M. (2022) · Molecules · doi:10.3390/molecules27196602 · Cited by 49 · cited 1×
“…with different resolution make it a successful choice for the targeted screening and quantitation of pharmacologically active compounds and their metabolites in biological specimens in routine applications (Ahmed et al. 2022; Di Trana et al. 2020; D’Ovidio et al. 2023; Vaiano et al. 2021).”
LC-MS/MS Application in Pharmacotoxicological Field: Current State and New Applications
D’Ovidio, C., Locatelli, M., Perrucci, M., Ciriolo, L., Furton, K. G., Gazioğlu, I., Kabir, A., Merone, G. M., de Grazia, U., Ali, I., et al. (2023) · Molecules · doi:10.3390/molecules28052127 · Cited by 49 · cited 1×
“…with different resolution make it a successful choice for the targeted screening and quantitation of pharmacologically active compounds and their metabolites in biological specimens in routine applications (Ahmed et al. 2022; Di Trana et al. 2020; D’Ovidio et al. 2023; Vaiano et al. 2021).”
De Luca, M. A., Tocco, G., Mostallino, R., Laus, A., Caria, F., Musa, A., Pintori, N., Ucha, M., Poza, C., Ambrosio, E., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109263 · Cited by 48 · cited 1×
“Similarly, De Luca et al. (2022) investigated the μ-opioid-like properties of isotonitazene, metonitazene, and piperi-dylthiambutene, showing that isotonitazene and metonita-zene exhibited higher potency than DAMGO (a synthetic opioid peptide with high μ-opioid receptor specificity) in in vitro…”
Vandeputte, M. M., Verougstraete, N., Walther, D., Glatfelter, G. C., Malfliet, J., Baumann, M. H., Verstraete, A. G., & Stove, C. P. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03294-2 · Cited by 44 · cited 2×
“…(such as qToF and Orbitrap), capillary electrophoresis (CE), X-ray crystallography, X-ray diffractometry, and UV–Vis spectrophotometry (Blanck-aert et al. 2021; Kanamori et al. 2023; Killoran et al. 2024; Monti et al. 2024; Mueller et al. 2021; Siczek et al. 2021; Vandeputte et al. 2022b).”
InfluentialControl of fentanyl-related substances in China
Bao, Y., Meng, S., Shi, J., & Lü, L. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30218-4 · Cited by 42 · cited 1×
“This is probably as a consequence of legal restriction in USA and China (Bao et al. 2019; Papsun et al. 2022).”
Kozell, L. B., Eshleman, A. J., Wolfrum, K. M., Swanson, T. L., Bloom, S. H., Benware, S., Schmachtenberg, J. L., Schutzer, K. A., Schutzer, W. E., Janowsky, A., et al. (2024) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.002052 · Cited by 42
Shifting drug markets in North America - a global crisis in the making?
Meyer, M., Westenberg, J. N., Jang, K. L., Choi, F., Schreiter, S., Mathew, N., King, C., Lang, U. E., Vogel, M., & Krausz, R. M. (2023) · International Journal of Mental Health Systems · doi:10.1186/s13033-023-00601-x · Cited by 41 · cited 1×
“In Canada, drug seizure data reveal that fentanyl is still currently the most seized opioid, but on the verge of being replaced by more potent synthetic opioids like carfentanil (Meyer et al. 2023).”
Butelman, E. R., France, C. P., & Woods, J. H. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10244-9 · Cited by 40 · cited 1×
“Experiments conducted on squirrel monkeys, dogs, and monkeys confirmed the respiratory paralysis and locomotor collapse caused by etonitazene at variable doses and with different order of appearance according to the animal model (Butelman et al. 1993; Carregal and Williams 1967).”
Nitazenes represent a growing threat to public health in Europe
Giraudon, I., Abel-Ollo, K., Vanaga-Arāja, D., Heudtlass, P., & Griffiths, P. (2024) · The Lancet Public Health · doi:10.1016/s2468-2667(24)00024-0 · Cited by 40 · cited 1×
“From 2022 to 2023, nitazenes (primarily isotonitazene, protonitazene, and metonitazene) related deaths increased from 39 to 48% in Estonia and from 3 to 29% in Latvia, respectively (Giraudon et al. 2024).”
Taoussi, O., Berardinelli, D., Zaami, S., Tavoletta, F., Basile, G., Kronstrand, R., Auwärter, V., Busardò, F. P., & Carlier, J. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03735-0 · Cited by 40
Blanckaert, P., Balcaen, M., Vanhee, C., Risseeuw, M., Canfyn, M., Desmedt, B., Van Calenbergh, S., & Deconinck, E. (2021) · Drug Testing and Analysis · doi:10.1002/dta.3113 · Cited by 39
Analysis of highly potent synthetic opioid nitazene analogs and their positional isomers
Kanamori, T., Okada, Y., Segawa, H., Yamamuro, T., Kuwayama, K., Tsujikawa, K., & Iwata, Y. T. (2023) · Drug Testing and Analysis · doi:10.1002/dta.3415 · Cited by 39 · cited 1×
“…(such as qToF and Orbitrap), capillary electrophoresis (CE), X-ray crystallography, X-ray diffractometry, and UV–Vis spectrophotometry (Blanck-aert et al. 2021; Kanamori et al. 2023; Killoran et al. 2024; Monti et al. 2024; Mueller et al. 2021; Siczek et al. 2021; Vandeputte et al. 2022b).”
Vandeputte, M. M., Tsai, M.-H. M., Chen, L., Glatfelter, G. C., Walther, D., Stove, C. P., Shi, L., & Baumann, M. H. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.109939 · Cited by 39 · cited 1×
“In vivo potencies for antinociception and cata-lepsy (measured as ED 50 s values) showed strong correlation with in vitro functional potencies (EC 50 s values) but not with MOR-binding affinities ( K i s values) (Vandeputte et al. 2023).”
Schüller, M., Lucic, I., Øiestad, Å. M. L., Pedersen-Bjergaard, S., & Øiestad, E. L. (2023) · Journal of Analytical Toxicology · doi:10.1093/jat/bkad071 · Cited by 37 · cited 1×
“Several authors (Parks et al. 2024; Walton et al. 2022; Krotulski et al. 2020, 2021; Pucci et al. 2024; Schüller et al. 2023; Diekhans et al. 2024; Pardi et al. 2023) have developed and validated quantitative methods to detect nitazene analogs with LODs and LOQs at a near or sub ng/mL.”
Pucci, M., Singh Jutley, G., Looms, J., & Ford, L. (2024) · Clinical Toxicology · doi:10.1080/15563650.2024.2309321 · Cited by 37 · cited 1×
“Several authors (Parks et al. 2024; Walton et al. 2022; Krotulski et al. 2020, 2021; Pucci et al. 2024; Schüller et al. 2023; Diekhans et al. 2024; Pardi et al. 2023) have developed and validated quantitative methods to detect nitazene analogs with LODs and LOQs at a near or sub ng/mL.”
Rapid in-plate generation of benzimidazole libraries and amide formation using EEDQ
Thomas, J. B., Fall, M. J., Cooper, J., Burgess, J. P., & Carroll, F. I. (1997) · Tetrahedron Letters · doi:10.1016/s0040-4039(97)01136-2 · Cited by 36 · cited 1×
“Moreover, no purification of the products was needed as the byproducts, ethanol and quinoline, were removed under the reaction conditions (Thomas et al. 1997).”
Kongshaug, K. E., Pedersen‐Bjergaard, S., Rasmussen, K. E., & Krogh, M. (1999) · Chromatographia · doi:10.1007/bf02490660 · Cited by 34
Ververi, C., Galletto, M., Massano, M., Alladio, E., Vincenti, M., & Salomone, A. (2024) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2024.115975 · Cited by 34 · cited 1×
“Ververi et al. (2024) applied UHPLC–MS/MS (QQQ configuration) to the detection of a series of eight analogs (plus brorphine).”
Killoran, S., McNamara, S., Kavanagh, P., O'Brien, J., & Lakes, R. (2025) · Drug Testing and Analysis · doi:10.1002/dta.3707 · Cited by 34 · cited 1×
“…(such as qToF and Orbitrap), capillary electrophoresis (CE), X-ray crystallography, X-ray diffractometry, and UV–Vis spectrophotometry (Blanck-aert et al. 2021; Kanamori et al. 2023; Killoran et al. 2024; Monti et al. 2024; Mueller et al. 2021; Siczek et al. 2021; Vandeputte et al. 2022b).”
Nitazene test strips: a laboratory evaluation
De Vrieze, L. M., Stove, C. P., & Vandeputte, M. M. (2024) · Harm Reduction Journal · doi:10.1186/s12954-024-01078-8 · Cited by 34
Walton, S. E., Krotulski, A. J., Glatfelter, G. C., Walther, D., Logan, B. K., & Baumann, M. H. (2023) · Psychopharmacology · doi:10.1007/s00213-022-06292-5 · Cited by 33
Williams, S. F., Stokes, R., Tang, P. L., & Blanco, A. M. (2023) · Analytical Methods · doi:10.1039/d3ay00766a · Cited by 33 · cited 1×
“…to quickly identify NPS on site at low operating costs, minimal technical training of personnel but with competitive analytical performance in terms of limit of detection, specificity, and selectivity (Gozdzialski et al. 2023; Harper et al. 2017; Mullin et al. 2023; Williams et al. 2023).”
The public health risks of counterfeit pills
Friedman, J., & Ciccarone, D. (2025) · The Lancet Public Health · doi:10.1016/s2468-2667(24)00273-1 · Cited by 32 · cited 1×
“Nitazenes as a subclass of NPS are particularly potent compounds, but they have not been sold as a drug their own but as adulterants in street polydrug doses or as coun-terfeit prescription drugs (Friedman and Ciccarone 2025).”
Etonitazine-induced rigidity and its antagonism by centrally acting muscle relaxants
Barnett, A., Goldstein, J. M., Fiedler, E. D., & Taber, R. I. (1975) · European Journal of Pharmacology · doi:10.1016/0014-2999(75)90197-1 · Cited by 30 · cited 1×
“The opioid receptor antagonist naloxone was able to prevent both muscle rigidity and cata-lepsy, while diazepam or other muscle relaxants were effective only on muscle rigidity suggesting treatment options for etonitazene overdose in humans (Barnett et al. 1975).”
�ber neue starkwirkende Analgetika und ihre klinische Erprobung
Bromig, G. (1958) · Klinische Wochenschrift · doi:10.1007/bf01486702 · Cited by 29 · cited 1×
“Metonitazene, alongside clonitazene and etonitazene, was one of the few 2-benzylbenzimidazole compounds studied in clinical trials as an analgesic in postoperative or trauma patients during the late 1950s (Bromig 1958).”
Pardi, J., Ford, S., & Cooper, G. (2023) · Journal of Analytical Toxicology · doi:10.1093/jat/bkad062 · Cited by 29 · cited 1×
“Several authors (Parks et al. 2024; Walton et al. 2022; Krotulski et al. 2020, 2021; Pucci et al. 2024; Schüller et al. 2023; Diekhans et al. 2024; Pardi et al. 2023) have developed and validated quantitative methods to detect nitazene analogs with LODs and LOQs at a near or sub ng/mL.”
Metabolic characterization of the new benzimidazole synthetic opioids - nitazenes
Jadhav, G. R., & Fasinu, P. S. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1434573 · Cited by 29
Barone, R., Pelletti, G., Giorgetti, A., Mohamed, S., Pascali, J. P., Sablone, S., Introna, F., & Pelotti, S. (2024) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2024.116054 · Cited by 28
Bade, R., Nadarajan, D., Hall, W., Brown, J. A., NPS Wastewater Consortium, & Schumann, J. (2025) · Addiction · doi:10.1111/add.70027 · Cited by 28 · cited 1×
“The order of magnitude of the water flow during the sampling period (megaliters) makes the analyte concentration as low as 0.01 ng/L. Bade et al. (2023, 2024) coped this issue mainly by solid-phase extraction (SPE) and concentration followed by LC–MS/MS. Chromatography separation was obtained on a…”
InfluentialSiczek, M., Zawadzki, M., Siczek, M., Chłopaś-Konowałek, A., & Szpot, P. (2021) · Forensic Toxicology · doi:10.1007/s11419-020-00552-9 · Cited by 27 · cited 1×
“…(such as qToF and Orbitrap), capillary electrophoresis (CE), X-ray crystallography, X-ray diffractometry, and UV–Vis spectrophotometry (Blanck-aert et al. 2021; Kanamori et al. 2023; Killoran et al. 2024; Monti et al. 2024; Mueller et al. 2021; Siczek et al. 2021; Vandeputte et al. 2022b).”
Development of a New LC-MS/MS Screening Method for Detection of 120 NPS and 43 Drugs in Blood
Vaiano, F., Bertol, E., Mineo, M., Pietrosemoli, L., Rubicondo, J., Supuran, C. T., & Carta, F. (2021) · Separations · doi:10.3390/separations8110221 · Cited by 27 · cited 1×
“…with different resolution make it a successful choice for the targeted screening and quantitation of pharmacologically active compounds and their metabolites in biological specimens in routine applications (Ahmed et al. 2022; Di Trana et al. 2020; D’Ovidio et al. 2023; Vaiano et al. 2021).”
Berardinelli, D., Taoussi, O., Carlier, J., Tini, A., Zaami, S., Sundermann, T., Busardò, F. P., & Auwärter, V. (2024) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-1360 · Cited by 26 · cited 1×
“Berardinelli et al. (2024) investigated the in vitro (pHLM) and in vivo (urine) metabolism of etonitazepipne, also known as N -pyrrolidino etonitazene.”
Ameline, A., Gheddar, L., Pichini, S., Stove, C., Aknouche, F., Maruejouls, C., Raul, J.-S., & Kintz, P. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119764 · Cited by 26 · cited 1×
“Similarly, Ameline et al. (2024) investigated the in vitro metabolism of protonitazene using pHLM and compared the results to the analysis of urine samples from two fatal intoxication cases.”
Recent advances in the detection of drugs of abuse by dried blood spots
Ververi, C., Vincenti, M., & Salomone, A. (2022) · Biomedical Chromatography · doi:10.1002/bmc.5555 · Cited by 25 · cited 1×
“Recent advancements have focused on automating sample preparation and analysis to further enhance its applicability (Stove et al. 2012; Ververi et al. 2023).”
Analysis of over 250 novel synthetic opioids and xylazine by LC–MS-MS in blood and urine
Diekhans, K., Yu, J., Farley, M., & Rodda, L. N. (2024) · Journal of Analytical Toxicology · doi:10.1093/jat/bkae009 · Cited by 25 · cited 1×
“Several authors (Parks et al. 2024; Walton et al. 2022; Krotulski et al. 2020, 2021; Pucci et al. 2024; Schüller et al. 2023; Diekhans et al. 2024; Pardi et al. 2023) have developed and validated quantitative methods to detect nitazene analogs with LODs and LOQs at a near or sub ng/mL.”
NOpiates: Novel Dual Action Neuronal Nitric Oxide Synthase Inhibitors with μ-Opioid Agonist Activity
Renton, P., Green, B., Maddaford, S., Rakhit, S., & Andrews, J. S. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200268w · Cited by 23
Feeney, W., Moorthy, A. S., & Sisco, E. (2022) · Forensic Chemistry · doi:10.1016/j.forc.2022.100459 · Cited by 23 · cited 1×
“However, despite important progress (Feeney et al. 2022; Hardwick and Tyler Davidson 2024), it may suffer from inadequate sensitivity and still lead to false-negative results.”
Kimani, M. M., Kern, S., Lanzarotta, A., Thatcher, M., Lorenz, L. M., Smith, S. W., Collins, M., Howe, G. W., & Wetherby, A. E. (2023) · Drug Testing and Analysis · doi:10.1002/dta.3440 · Cited by 23 · cited 1×
“Kimani et al. (2023) reported about this toolkit in a Food and Drug Administration (FDA) on-site satellite laboratory to detect fentanyl and nitazene analogs in fake oxycodone HCl 30 mg tablets seized at an International Mail Facility.”
Parks, C., Maskell, P., McKeown, D. A., & Couchman, L. (2024) · Journal of Analytical Toxicology · doi:10.1093/jat/bkae076 · Cited by 23 · cited 3×
“…reported to be significantly less active than its parent compound (Vandeputte et al. 2021), the detection of such metabolite may avoid underreporting cases of nitazene use as the parent compound may be undetected due to an extensive in vivo metabolism or bacterial degradation (Parks et al. 2024).”
Alhosan, N., Cavallo, D., Santiago, M., Kelly, E., & Henderson, G. (2025) · British Journal of Pharmacology · doi:10.1111/bph.17376 · Cited by 23 · cited 1×
“In a recent work, Alhosan et al. (2025) studied the potency, dissociation kinetics and antagonism by naloxone at the MOR receptor for some fentanyls and nitazenes (iso-tonitazene and etonitazene), with morphine and DAMGO as reference compounds.”
Killeen, N., Lakes, R., Webster, M., Killoran, S., McNamara, S., Kavanagh, P., Eagleton, M., McCormack, S., Micheau, E., Moughty, A., et al. (2024) · Addiction · doi:10.1111/add.16525 · Cited by 22 · cited 1×
“In November and December 2023, in the cities of Dublin and Cork, Ireland, 77 overdose cases were linked to etoni-tazepyne ( N -pyrrolidino etonitazene) and protonitazepyne ( N -pyrrolidino protonitazene), sold as street heroin (Killeen et al. 2024).”
Murari, M., Pesavento, S., Greco, F., Vettori, A., Tagliaro, F., & Gottardo, R. (2024) · Drug Testing and Analysis · doi:10.1002/dta.3590 · Cited by 21 · cited 1×
“Murari et al. (2024) studied the metabolism and toxicity of several nitazene opioids including isotonitazene, flu-nitazene, etodesnitazene, metonitazene, metodesnitazene, N -pyrrolidino etonitazene (etonitazepyne), and butonitazene, in a zebrafish early life stages model.”
Sisco, E., Appley, M. G., Pyfrom, E. M., Banta-Green, C. J., Shover, C. L., Molina, C. A., Biamont, B., & Robinson, E. L. (2024) · Forensic Chemistry · doi:10.1016/j.forc.2024.100594 · Cited by 21
Nadarajan, D., O'Brien, J. W., Cresswell, S. L., Kele, B., Mueller, J. F., & Bade, R. (2024) · Analytica Chimica Acta · doi:10.1016/j.aca.2024.343036 · Cited by 20 · cited 1×
“LOD ranged from 0.16 to 0.2 ng/L, while LOQ was 0.5 ng/L. Nadarajan et al. (2024) tested the same chromatographic conditions, but the sample was simply filtered without concentration on SPE and the resulting LOD and LOQ were in the range 5.2–214 and 16–649 ng/L, respectively, for different…”
InfluentialStructural Characterization of Nitazene Analogs Using Electron Ionization-Mass Spectrometry (EI-MS)
Hardwick, E. K., & Tyler Davidson, J. (2024) · Forensic Chemistry · doi:10.1016/j.forc.2024.100605 · Cited by 20 · cited 1×
“However, despite important progress (Feeney et al. 2022; Hardwick and Tyler Davidson 2024), it may suffer from inadequate sensitivity and still lead to false-negative results.”
Synthetic Illicit Opioids in Brazil: Nitazenes Arrival
Gonçalves de Araújo, K. R., Fabris, A. L., Junior, L. F. N., Soares, A. L., Costa, J. L., & Yonamine, M. (2024) · Forensic Science International Reports · doi:10.1016/j.fsir.2024.100375 · Cited by 19
Vitrano, A., Giorgi, A. D., Abbate, V., Basile, G., Maida, N. L., Pichini, S., & Trana, A. D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212332 · Cited by 19 · cited 1×
“Vitrano et al. (2024) based their approach on UHPLC–HRMS (Quadrupole–Orbit-rap configuration) equipped with a biphenyl column; four nitazenes analogs (etazene, flunitazene, isotonitazene, and protonitazene) were the target compounds.”
Naloxone Dosing and Hospitalization for Nitazene Overdose: A Scoping Review
Berger, J. C., Severe, A. D., Jalloh, M. S., & Manini, A. F. (2025) · Journal of Medical Toxicology · doi:10.1007/s13181-025-01059-8 · Cited by 19 · cited 1×
“However, with the advent first of fentanyls (Moss and Carlo 2019) and now of nitazenes (Berger et al. 2025), the overdose reversal through naloxone seems to require higher or repeated doses.”
Monti, M. C., De Vrieze, L. M., Vandeputte, M. M., Persson, M., Gréen, H., Stove, C. P., & Schlotterbeck, G. (2024) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2024.116453 · Cited by 18 · cited 2×
“…(such as qToF and Orbitrap), capillary electrophoresis (CE), X-ray crystallography, X-ray diffractometry, and UV–Vis spectrophotometry (Blanck-aert et al. 2021; Kanamori et al. 2023; Killoran et al. 2024; Monti et al. 2024; Mueller et al. 2021; Siczek et al. 2021; Vandeputte et al. 2022b).”
Grigoryev, A., Kavanagh, P., Dowling, G., & Rodin, I. (2023) · Journal of Analytical Toxicology · doi:10.1093/jat/bkac001 · Cited by 16
Mullin, A., Scott, M. L., Vaccaro, G., Gittins, R., Ferla, S., Schifano, F., & Guirguis, A. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20064793 · Cited by 16 · cited 1×
“…to quickly identify NPS on site at low operating costs, minimal technical training of personnel but with competitive analytical performance in terms of limit of detection, specificity, and selectivity (Gozdzialski et al. 2023; Harper et al. 2017; Mullin et al. 2023; Williams et al. 2023).”
Kanamori, T., Okada, Y., Segawa, H., Yamamuro, T., Kuwayama, K., Tsujikawa, K., & Iwata, Y. T. (2025) · Drug Testing and Analysis · doi:10.1002/dta.3705 · Cited by 16 · cited 1×
“N -desethyl, N , N -didesethyl, O -desalkyl, N -desethyl- O -desalkyl, N , N -didesethyl- O -desalkyl, and N -oxidated metabolites were recently detected by Kanamori et al. (2025) as phase I metabolites after hydrolysis of incubates of metonitazene, etonitazene, and protonitazene with HE.”
Gao, G., Yang, S., Wang, X., Xiang, P., Ma, L., Yan, F., & Shi, Y. (2025) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2025.116707 · Cited by 16 · cited 1×
“As regard to the number of compounds, the field of application for an HPLC–MS/MS analysis of hair has been improved by Gao et al. (2025) who validated a method for 17 analogs.”
Etonitazene. Improved synthesis
Carroll, F. I., & Coleman, M. C. (1975) · Journal of Medicinal Chemistry · doi:10.1021/jm00237a024 · Cited by 15
Lanzarotta, A. C., Kern, S. E., Batson, J. S., Falconer, T. M., Fulcher, M., Gaston, K. W., Kimani, M. M., Lorenz, L., Morales‐Garcia, F., Ranieri, N., et al. (2021) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2021.114183 · Cited by 15 · cited 1×
“…infra-red spectrometer (FTIR), and a direct analysis in real-time ambient ionization coupled to a thermal desorption unit and a mass spectrometer (DART-TD-MS), has proved successful in detecting pharmaceutical ingredients in drug products during mail controls (Lanzarotta et al. 2021, 2023, 2024).”
Identification of etazene (etodesnitazene) metabolites in human urine by LC‐HRMS
Verougstraete, N., Verhaeghe, A., Germonpré, J., Lebbinck, H., & Verstraete, A. G. (2023) · Drug Testing and Analysis · doi:10.1002/dta.3377 · Cited by 15 · cited 1×
“…etodesnitazene-positive cases, O -desethyl etodesnitazene was preponderant in hydrolyzed urine samples, which was in line with the metabolites found in the urine of 25-year-old man intoxicated with a polydrug mixture in 2022 (etodesnitazene was among the drugs detected) (Verougstraete et al. 2023).”
Testing for Protonitazene in Human Hair Using LC–MS-MS
Kintz, P., Ameline, A., Gheddar, L., Pichini, S., Mazoyer, C., Teston, K., Aknouche, F., & Maruejouls, C. (2024) · Journal of Analytical Toxicology · doi:10.1093/jat/bkae050 · Cited by 15 · cited 1×
“Kintz et al. (2024) and Bar-one et al. (2024) published two validated methods based on LC–MS/MS to detect protonitazene and 7 nitazene analogs (butonitazene, etodesnitazene, flunitazene, isotonitazene, metodesnitazene, metonitazene, and N -pyrrolidino etonita-zene), respectively.”
Wet-Chemical Synthesis of TiO2/PVDF Membrane for Energy Applications
Saleem, M. H., Albaqami, M. D., Bahajjaj, A. A. A., Ahmed, F. U., Din, E., Arifeen, W. U., & Ali, S. (2022) · Molecules · doi:10.3390/molecules28010285 · Cited by 14
Differential motor effects of intraventricular infusion of morphine and etonitazene
Shizgal, P., Sklar, L. S., Brown, Z. W., & Amit, Z. (1977) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(77)90154-x · Cited by 13 · cited 1×
“Moreover, intraventricular injection of etonitazene (9.2 μg total dose) in rats produced extreme muscle rigidity, while morphine (160–385 μg dose range) induced explosive motor behavior (Shizgal et al. 1977).”
InfluentialSimilarities of the cataleptic state induced by β-endorphin and morphine
Rondeau, D. B., Turcotte, M. C., Young, L., & Hebert, D. (1982) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(82)90350-1 · Cited by 12 · cited 1×
“On the other hand, lower intraventricular doses of etonitazene (2 µg) and a parenteral dose of 20 mg/kg of morphine-induced catalepsy, hypore-flexia, and muscle rigidity (Rondeau et al. 1982).”
Lanzarotta, A. C., Kern, S. E., Batson, J. S., Boyd, B., Kimani, M. M., Kuo, W., LaGarde, D., Loh, M., Adeoshun, L. L., Lorenz, L., et al. (2022) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2022.115153 · Cited by 12 · cited 1×
“…infra-red spectrometer (FTIR), and a direct analysis in real-time ambient ionization coupled to a thermal desorption unit and a mass spectrometer (DART-TD-MS), has proved successful in detecting pharmaceutical ingredients in drug products during mail controls (Lanzarotta et al. 2021, 2023, 2024).”
Huang, B., Hua, Z., Liu, C., Li, J., Shu, J., & Li, Z. (2025) · Drug Testing and Analysis · doi:10.1002/dta.3838 · Cited by 10 · cited 1×
“Similar results were obtained by Huang et al. (2024) for N -pyrrolidino etonitazene, whose major metabolites generated from O -dealkylation and O -dealkylation and oxidation of the pyrrolidine ring via formation of a double bond, thus suggesting that dealkylation of the tertiary amine is not…”
Buratti, E., Mietti, G., Cerioni, A., Cippitelli, M., Froldi, R., Cingolani, M., & Scendoni, R. (2024) · Journal of Forensic and Legal Medicine · doi:10.1016/j.jflm.2024.102710 · Cited by 6 · cited 1×
“Buratti et al. (2024) developed a targeted analytical method to identify and quantitate etonitazepipne through a UHPLC–HRMS (Orbitrap configuration) in blood, vitreous humor, and gastric contents from a corpse in an advanced state of decomposition.”
Effects of etonitazene upon respiratory neurons
Carregal, E. J. A., & Williams, B. (1967) · Cellular and Molecular Life Sciences · doi:10.1007/bf02142268 · Cited by 4 · cited 1×
“Experiments conducted on squirrel monkeys, dogs, and monkeys confirmed the respiratory paralysis and locomotor collapse caused by etonitazene at variable doses and with different order of appearance according to the animal model (Butelman et al. 1993; Carregal and Williams 1967).”
Lanzarotta, A. C., Kern, S. E., Batson, J. S., Collins, M., Patel, A., Altaf, M., Arrecis, J., Boyd, B., Illan, F. G., Griffin, K. M., et al. (2024) · Journal of Forensic Sciences · doi:10.1111/1556-4029.15537 · Cited by 4 · cited 1×
“…infra-red spectrometer (FTIR), and a direct analysis in real-time ambient ionization coupled to a thermal desorption unit and a mass spectrometer (DART-TD-MS), has proved successful in detecting pharmaceutical ingredients in drug products during mail controls (Lanzarotta et al. 2021, 2023, 2024).”
Power, A., Gardner, M., Andrews, R. C., Cozier, G. E., Kumar, R. R., Freeman, T. P., Blagbrough, I. S., Scott, J., Frinculescu, A., Shine, T., et al. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-f5tq3-v2 · Cited by 2
Bade, R., Nadarajan, D., Hall, W., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4943741 · Cited by 1
Response to “Comment on Naloxone Dosing and Hospitalization for Nitazene Overdose: A Scoping Review”
Berger, J., Jalloh, M. A., Severe, A. D., & Manini, A. F. (2025) · Journal of Medical Toxicology · doi:10.1007/s13181-025-01071-y · Cited by 1
Alhosan, N., Cavallo, D., Santiago, M., Kelly, E., & Henderson, G. (2024) · doi:10.1101/2024.06.04.597322 · Cited by 1
Research works printed but not linked: 1
- Sorokin VI (1999) Illegal synthesis of etonitazene. J Clandestine Lab Invest Chem Assoc 9:20
Cited by
Zhu, D. T., Fitzgerald, N. D., Palamar, J. J., & Krotulski, A. J. (2026) · Addiction · doi:10.1111/add.70378 · Cited by 8
“Although this action aimed to reduce IMF availability, it may have inadvertently created an opening for the introduction of a new sub-class of synthetic opioids: nitazene analogs [3, 5, 6].”
Verma, A., Ogunsola, S. S., Keith, K. A., & Jayawardana, G. D. T. L. (2025) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2025.104880 · Cited by 4
Xu, D., Li, J., & Yan, H. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04813-5 · Cited by 3
Al-Juhani, A., Alasmari, A., Aljohani, O. O., Hakeem, H., Desoky, R., Badghaish, M. A., Aljohani, N., & Alanazi, F. A. (2025) · Cureus · doi:10.7759/cureus.99109 · Cited by 1
“However, current research exhibits significant variability in sample preparation, analogue makeup, dilution techniques, ambient conditions, and interpretation guidelines, hindering the capacity to draw conclusive determinations regarding their trustworthiness [10,11,12].”
Maillot, A., Guyon, J., Ma-Tsi-Leong, M., Berly, L., Weisse, F., Mahé, A., Roux, G. L., Nativel, F., Daveluy, A., Puech, B., et al. (2025) · International Journal of Emergency Medicine · doi:10.1186/s12245-025-01055-3 · Cited by 1
“NSOs, particularly fentanyl analogues and benzimidazole derivatives, rank among the most lethal NPS worldwide [28].”
Metadata
- Authors
- Caprari, C., Ferri, E., Rossetti, P., Gregori, A., Citti, C., & Cannazza, G.
- Affiliations
- University of Modena and Reggio Emilia (IT)
- Arma dei Carabinieri (IT)
- Corresponding author
- Caprari, Cristian
- Citti, Cinzia
- Venue
- Archives of Toxicology
- Published
- 2025-06-09
- Volume
- 99
- Issue
- 10
- Pages
- 3877-3896
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- OpenAlex
- W4411145858
- Cited by
- 19
- References
- 94
- Citations by year
- 2026: 12 · 2025: 7
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Archives of Toxicology (publishedVersion)
- PubMed (publishedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
- Keywords
- nitazenes, synthetic opioids, isotonitazene, opioid overdose deaths, opioid epidemic, fentanyl analogs, opioid agonists, forensic toxicology, drug metabolites, pharmacokinetics, pharmacodynamics, illicit drug markets
- MeSH terms
- Synthetic Drugs, Opioid Epidemic, Analgesics, Opioid, Animals, Fentanyl, Humans, Opioid-Related Disorders, Illicit Drugs, Thiazoles, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.